Leonteq Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$570K Sell
1,090
-3,343
-75% -$1.71M 0.02% 320
2026
Q2
$2.2M Buy
4,433
+173
+4% +$76.7K 0.08% 171
2026
Q1
$1.9M Sell
4,260
-766
-15% -$357K 0.07% 204
2025
Q4
$2.28M Sell
5,026
-2,002
-28% -$863K 0.07% 203
2025
Q3
$2.75M Buy
7,028
+2,473
+54% +$1.03M 0.08% 166
2025
Q2
$2.03M Sell
4,555
-1,265
-22% -$583K 0.08% 159
2025
Q1
$2.8M Sell
5,820
-836
-13% -$390K 0.16% 125
2024
Q4
$2.68M Buy
6,656
+2,285
+52% +$1.06M 0.18% 120
2024
Q3
$2.03M Sell
4,371
-1,262
-22% -$606K 0.15% 132
2024
Q2
$2.64M Buy
5,633
+245
+5% +$106K 0.19% 103
2024
Q1
$2.25M Sell
5,388
-695
-11% -$294K 0.17% 135
2023
Q4
$2.48M Buy
6,083
+4,001
+192% +$1.48M 0.14% 140
2023
Q3
$724K Sell
2,082
-277
-12% -$96.9K 0.04% 298
2023
Q2
$830K Buy
2,359
+400
+20% +$135K 0.04% 305
2023
Q1
$617K Sell
1,959
-747
-28% -$224K 0.03% 333
2022
Q4
$781K Sell
2,706
-11
-0.4% -$3.35K 0.03% 315
2022
Q3
$787K Sell
2,717
-390
-13% -$112K 0.03% 303
2022
Q2
$876K Sell
3,107
-2,549
-45% -$682K 0.03% 305
2022
Q1
$1.48M Sell
5,656
-8,064
-59% -$1.91M 0.05% 234
2021
Q4
$3.01M Sell
13,720
-27,760
-67% -$5.4M 0.11% 161
2021
Q3
$7.52M Buy
41,480
+15,666
+61% +$3.06M 0.32% 79
2021
Q2
$5.2M Buy
25,814
+2,925
+13% +$612K 0.31% 67
2021
Q1
$4.92M Buy
22,889
+14,598
+176% +$3.21M 0.29% 79
2020
Q4
$1.96M Buy
+8,291
New +$1.9M 0.1% 165

Other funds holding VRTX

Leonteq Securities's VRTX Position: Q3 2026 in Review

Leonteq Securities reduced its Vertex Pharmaceuticals (VRTX) stake by 75% in Q3 2026, selling an estimated $1.71M and leaving 1,090 shares worth $570K. The position accounts for 0.02% of the portfolio, ranked #320.

Leonteq Securities first reported a position in VRTX in Q4 2020 and has held it in 24 quarters since. The position peaked at $7.52M in Q3 2021. 1,786 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Leonteq Securities held 1,090 shares of Vertex Pharmaceuticals worth $570K as of Q3 2026.
  • Leonteq Securities sold 3,343 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.71M.
  • Vertex Pharmaceuticals made up 0.02% of Leonteq Securities's portfolio in Q3 2026, its #320 holding.
  • Leonteq Securities first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
  • Leonteq Securities's Vertex Pharmaceuticals position peaked at $7.52M in Q3 2021.
  • 1,786 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.